STAAR Surgical (STAA) shares are soaring 5.05% in intraday trading on Thursday, following the company's strong third-quarter results and a statement from Yunqi Capital. The investment firm has expressed its approval of STAAR's performance while reiterating its opposition to the proposed sale of the company to Alcon.
Yunqi Capital's endorsement of STAAR Surgical's Q3 results appears to have bolstered investor confidence in the company's standalone prospects. The investment firm's continued resistance to the Alcon deal suggests that STAAR may have the potential for greater value creation as an independent entity. This combination of strong financial performance and the possibility of remaining independent seems to be driving the significant uptick in STAAR's stock price today.